Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
11/25/1990 | WO1990014007A1 Method for protection from azt side effects and toxicity |
11/25/1990 | CA2057900A1 Method for protection from azt side effects and toxicity |
11/22/1990 | EP0398709A2 Genetic diagnosis of torsion dystonia |
11/22/1990 | EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment |
11/22/1990 | EP0397798A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
11/22/1990 | EP0397764A1 Method of reducing immunoglobulin e responses |
11/22/1990 | CA2014036A1 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
11/20/1990 | US4971998 Menstruation, fenfluramine |
11/20/1990 | US4971991 Physiological function enhancing agents activated by ultrasonic waves for the treatment of tumors |
11/20/1990 | US4971795 Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype |
11/20/1990 | US4971785 Non-alcoholic delivery system for orally ingestible active ingredients |
11/20/1990 | CA1276640C Substituted anilines and processes for the preparation thereof |
11/20/1990 | CA1276556C Organic acid as catalysts for the erosion of polymers |
11/18/1990 | CA2016227A1 Genetic diagnosis of torsion dystonia |
11/17/1990 | CA2016895A1 Use of gestodene for the production of pharmaceutical agents |
11/16/1990 | WO1990014105A1 Accumulation of drugs into liposomes by a proton gradient |
11/16/1990 | CA2056435A1 Accumulation of drugs into liposomes by a proton gradient |
11/15/1990 | WO1990013650A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
11/15/1990 | WO1990013328A1 Dry powder inhalation device |
11/15/1990 | WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
11/15/1990 | WO1990013289A1 Antineoplastic solution and method for treating neoplasms |
11/15/1990 | CA2354096A1 Dry powder inhalation device |
11/14/1990 | EP0396560A1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans. |
11/13/1990 | US4970235 Medicaments containing of linolenic acid |
11/13/1990 | US4970202 Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs |
11/06/1990 | WO1990013299A1 Fertility enhancement |
11/06/1990 | CA2054197A1 Fertility enhancement |
11/06/1990 | CA1275951C Lysing or blocking unwanted cells |
11/06/1990 | CA1275928C Suppression of withdrawal symptoms in opioid-induced tolerance or dependence |
11/06/1990 | CA1275922C Treatment of cancer |
11/01/1990 | WO1990012594A1 Novel monoclonal antibody to novel antigen associated with human tumors |
11/01/1990 | WO1990012561A1 Cosmetic composition |
11/01/1990 | WO1990009789A3 Pharmaceutically active agents that impede amyloid formation in vivo |
11/01/1990 | CA2053305A1 Cosmetic composition |
10/31/1990 | EP0395294A2 Control of protozoal disease |
10/31/1990 | EP0394928A1 Topical antiviral pharmaceutical composition containing a nonionic surfactant |
10/31/1990 | EP0394920A1 Hair enrichment composition and method of use |
10/31/1990 | DE4011956A1 Verfahren und vorrichtung zur darstellung von sterilen einspritzbaren antibiotikapulvern Method and device for presentation of sterile injectable antibiotic powders |
10/30/1990 | US4966893 Method for treatment of senile dementia |
10/28/1990 | WO1990012597A1 Fibroblast growth factor conjugates |
10/28/1990 | WO1990012586A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
10/27/1990 | CA2012727A1 Process and an apparatus for the preparation of sterile injectable powders of antibiotics |
10/25/1990 | CA2015312A1 Control of protozoal disease |
10/24/1990 | EP0394050A2 A method of preparing a freeze-dried formulation containing a drug |
10/24/1990 | EP0393575A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent |
10/24/1990 | EP0393539A2 Oral preparation containing estradiol valerate |
10/24/1990 | EP0393441A1 Mercapto-acylamino acids |
10/24/1990 | CA2015206A1 Topical antiviral pharmaceutical composition containing a nonionic surfactant |
10/24/1990 | CA2014978A1 Hair enrichment composition and method of use |
10/23/1990 | US4965357 2,5,6-substituted N1 -alkylpyrimidines |
10/22/1990 | WO1990012569A1 Therapeutic use of 5-ht3 receptor antagonists |
10/22/1990 | CA2031214A1 Therapeutic use of 5-ht receptor antagonists |
10/21/1990 | WO1990012579A1 The use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
10/18/1990 | WO1990012091A1 Urokinase-type plasminogen activator receptor |
10/18/1990 | WO1990011781A1 The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
10/18/1990 | WO1990011769A1 Therapeutic compounds, compositions and uses thereof |
10/18/1990 | WO1990011766A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
10/18/1990 | WO1990011764A1 Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins |
10/18/1990 | WO1990011761A1 Treatment of aids dementia, myelopathy and blindness |
10/18/1990 | WO1990011758A2 Use of a potassic agonist in the treatment of glaucoma |
10/18/1990 | WO1990011734A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
10/17/1990 | EP0392300A1 Use of at least one cytokin for the manufacture of a medicament for the systemic treatment of preneoplastic lesions |
10/17/1990 | CA2014732A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent |
10/17/1990 | CA2014304A1 Monoclonal antibody to novel anitgen associated with human tumors |
10/16/1990 | CA1275246C Process for preparing immunogenic complex |
10/11/1990 | WO1990012003A1 Mercapto-acylamino acids |
10/11/1990 | DE3911202A1 Method for improving the tolerability of drugs which can be administered orally, and pharmaceutical compositions which can be administered orally |
10/11/1990 | CA2051652A1 Mercapto-acylamino acids |
10/11/1990 | CA2014130A1 Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions |
10/10/1990 | EP0391462A1 Synergistic compositions containing ketanserin |
10/10/1990 | EP0391224A2 Drugs and their uses for treating parasitosis |
10/10/1990 | EP0391172A1 Transdermal therapeutic system with an increased rate of flow of medicament and method for its manufacture |
10/10/1990 | CA2014282A1 Therapeutic compounds, compositions and uses thereof |
10/09/1990 | USRE33375 Treatments employing drug-containing matrices for introduction into cellular lesion areas |
10/09/1990 | US4962105 Selected from benazepril, benazeprilat, and libenzapril, by administering in combination specific pyridyl indole derivatives |
10/09/1990 | CA1275042A1 Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents |
10/08/1990 | CA2051676A1 Urokinase-type plasminogen activator receptor |
10/05/1990 | CA2013801A1 Synergistic compositions containing ketanserin |
10/04/1990 | WO1990011696A1 Reducing post-prandial plasma large neutral amino acid concentrations |
10/04/1990 | WO1990011085A1 Large multivalent immunogen |
10/04/1990 | WO1990006748A3 Use of certain herbicides in cancer treatment and production of protoporphyrin ix |
10/04/1990 | DE4010368A1 Mittel zur bekaempfung von aids-viren und anderen viren Funds to fight AIDS-virus and other viruses |
10/04/1990 | CA2050585A1 Reducing post-prandial plasma large neutral amino acid concentrations |
10/04/1990 | CA2013770A1 Use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
10/03/1990 | EP0390071A1 Preservative system for ophthalmic formulations |
10/03/1990 | CN1045791A Inhibition of hiv using synergistic combinations of nucleosides derivatives |
10/01/1990 | CA2013443A1 Pharmaceutical compositions and their use in the treatment of parasitoses |
09/26/1990 | EP0389177A2 Pharmaceutical formulation |
09/26/1990 | EP0388817A2 Use of mixed micelles and mixed micelle solutions of immunomodulators |
09/26/1990 | EP0388434A1 Differential delivery of therapeutic agents across the blood brain barrier |
09/25/1990 | US4959358 Drug administration |
09/23/1990 | WO1990011074A1 Parathyroid hypertensive factor |
09/21/1990 | CA2012492A1 Pharmaceutical formulation |
09/19/1990 | EP0388306A2 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics |
09/19/1990 | EP0387762A2 Medicament with positive inotropic activity, containing a synergistically active mixture consisting of a benzimidazole and a beta-blocker, its preparation and use |
09/19/1990 | EP0387647A2 High-dispersion pharmaceutical composition |
09/18/1990 | WO1990011081A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
09/18/1990 | US4957910 Method and composition for the treatment and prevention of viral infections |
09/18/1990 | CA2050473A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
09/18/1990 | CA1274140A1 Injecting apparatus for emergency treatment |